Phytochemical Profiling and Pharmacological Evaluation of Cocculus Hirsutus Extract for the Management of Chronic Inflammatory Skin Disorders
Keywords:
Cocculus hirsutus, phytochemical screening, total phenolic content, DPPH, oxazolone-induced dermatitis, anti-inflammatory, tacrolimus, Wistar ratsAbstract
Background: Chronic inflammatory skin disorders such as atopic dermatitis and psoriasis are managed largely with corticosteroids and calcineurin inhibitors, which are limited by relapse and adverse effects with prolonged use. Cocculus hirsutus (L.) W. Theob. (Menispermaceae) is a climbing herb used in Indian traditional medicine, but its activity against inflammatory skin disease has received little systematic study. Objective: To profile the phytochemical constituents of successive extracts of the whole plant, compare their antioxidant capacity, and assess the safety and anti-inflammatory potential of the most promising extract in a chronic dermatitis model. Methods: Powdered whole plant was extracted successively in a Soxhlet apparatus with petroleum ether, chloroform, methanol and water. Extracts were screened for major secondary metabolite classes, and total phenolic (TPC) and flavonoid (TFC) contents were measured spectrophotometrically. Radical scavenging was assessed by the DPPH assay (20–100 µg/mL) against ascorbic acid. The methanolic extract (MECH) was tested for acute oral toxicity (OECD 423) and for activity in oxazolone-induced chronic dermatitis in Wistar rats at 100, 200 and 400 mg/kg, with 0.1% tacrolimus ointment as reference. Results: Methanol gave the highest yield (10.87%), TPC (86.35 ± 1.24 mg GAE/g) and TFC (47.83 ± 0.92 mg QE/g). MECH was also the most active plant extract in the DPPH assay (85.72% at 100 µg/mL; estimated IC₅₀ 48.5 µg/mL, against 37.7 µg/mL for ascorbic acid). No mortality or toxic signs occurred at 2000 mg/kg. In oxazolone-induced dermatitis, MECH reduced the dermatitis score by 29.2%, 49.4% and 66.9% at 100, 200 and 400 mg/kg (tacrolimus 75.3%), and lowered skin thickness, serum TNF-α, IL-6 and IL-1β and the histological severity score in a dose-dependent manner (p < 0.001 versus disease control). Conclusion: The methanolic extract of C. hirsutus is rich in phenolic and flavonoid constituents, shows strong in-vitro antioxidant activity and was well tolerated at the limit dose, which supports its further development as a candidate for chronic inflammatory skin conditions
Downloads
References
1. Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396(10247):345-60. doi:10.1016/S0140-6736(20)31286-1
2. Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387(10023):1109-22. doi:10.1016/S0140-6736(15)00149-X
3. Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021;397(10281):1301-15. doi:10.1016/S0140-6736(20)32549-6
4. Boehncke WH, Schön MP. Psoriasis. Lancet. 2015;386(9997):983-94. doi:10.1016/S0140-6736(14)61909-7
5. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496-509. doi:10.1056/NEJMra0804595
6. Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem. 2015;97:55-74. doi:10.1016/j.ejmech.2015.04.040
7. Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020;21(7):363-83. doi:10.1038/s41580-020-0230-3
8. Shahidi F, Ambigaipalan P. Phenolics and polyphenolics in foods, beverages and spices: antioxidant activity and health effects – a review. J Funct Foods. 2015;18:820-97. doi:10.1016/j.jff.2015.06.018
9. Weng Z, Patel AB, Vasiadi M, Therianou A, Theoharides TC. Luteolin inhibits human keratinocyte activation and decreases NF-κB induction that is increased in psoriatic skin. PLoS One. 2014;9(2):e90739.
10. doi:10.1371/journal.pone.0090739
11. Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev.
12. 2009;2(5):270-8. doi:10.4161/oxim.2.5.9498
13. Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. ScientificWorldJournal. 2013;2013:162750. doi:10.1155/2013/162750
14. Logesh R, Das N, Adhikari-Devkota A, Devkota HP. Cocculus hirsutus (L.) W.Theob. (Menispermaceae): a review on traditional uses, phytochemistry and pharmacological activities. Medicines (Basel). 2020;7(11):69.
15. doi:10.3390/medicines7110069
16. Sangameswaran B, Jayakar B. Anti-inflammatory activity of aerial parts of Cocculus hirsutus (L) Diels. Plant Arch.
17. 2007;7(1):215-7. [No DOI assigned]
18. Chen H, Hong YH, Woo BY, Hong YD, Manilack P, Souladeth P, et al. Cocculus hirsutus ameliorates gastric and lung injuries by suppressing Src/Syk. Phytomedicine. 2021;93:153778. doi:10.1016/j.phymed.2021.153778
19. Shukla R, Rajpoot RK, Poddar A, et al. Cocculus hirsutus-derived phytopharmaceutical drug has potent anti-dengue activity. Front Microbiol. 2021;12:746110. doi:10.3389/fmicb.2021.746110
20. Man MQ, Hatano Y, Lee SH, et al. Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol. 2008;128(1):79-86. doi:10.1038/sj.jid.5700943
21. Jin H, He R, Oyoshi M, Geha RS. Animal models of atopic dermatitis. J Invest Dermatol. 2009;129(1):31-40. doi:10.1038/jid.2008.106
22. Bae Y, Kim T, Park N, Choi S, Yi D, Soto S, et al. Ameliorative effects of Daphnopsis costaricensis extract against oxazolone-induced atopic dermatitis-like lesions in BALB/c mice. Nutrients. 2022;14(21):4521.
23. doi:10.3390/nu14214521
24. Ruzicka T, Bieber T, Schöpf E, et al. A short-term trial of tacrolimus ointment for atopic dermatitis. N Engl J Med. 1997;337(12):816-21. doi:10.1056/NEJM199709183371204
25. Zhang QW, Lin LG, Ye WC. Techniques for extraction and isolation of natural products: a comprehensive review. Chin Med. 2018;13:20. doi:10.1186/s13020-018-0177-x
26. Harborne JB. Phytochemical methods: a guide to modern techniques of plant analysis. 3rd ed. London: Chapman & Hall; 1998. [Book; no DOI]
27. Singleton VL, Rossi JA. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic. 1965;16(3):144-58. [No DOI assigned]
28. Chang CC, Yang MH, Wen HM, Chern JC. Estimation of total flavonoid content in propolis by two complementary colorimetric methods. J Food Drug Anal. 2002;10(3):178-82. doi:10.38212/2224-6614.2748
29. Brand-Williams W, Cuvelier ME, Berset C. Use of a free radical method to evaluate antioxidant activity. LWT Food Sci Technol. 1995;28(1):25-30. doi:10.1016/S0023-6438(95)80008-5
30. Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410. doi:10.1371/journal.pbio.3000410
31. OECD. Test No. 423: acute oral toxicity – acute toxic class method. In: OECD guidelines for the testing of chemicals, Section 4. Paris: OECD Publishing; 2002. doi:10.1787/9789264071001-en
32. Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27-31. doi:10.4103/0976-0105.177703
33. Dunnett CW. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc. 1955;50(272):1096-121. doi:10.1080/01621459.1955.10501294
34. Alam MN, Bristi NJ, Rafiquzzaman M. Review on in vivo and in vitro methods evaluation of antioxidant activity. Saudi Pharm J. 2013;21(2):143-52. doi:10.1016/j.jsps.2012.05.002
35. Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023. doi:10.1038/sigtrans.2017.23
36. Dai J, Mumper RJ. Plant phenolics: extraction, analysis and their antioxidant and anticancer properties. Molecules. 2010;15(10):7313-52. doi:10.3390/molecules15107313
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.